跳至主要内容
临床试验/JPRN-UMIN000042397
JPRN-UMIN000042397已完成未知

Evaluation of the efficacy of the detection of the significant cancer and the safety in MRI-TRUS fusion image-guided prostate biopsy: multi-institutional study in Japan - Evaluation of the efficacy of the detection of the significant cancer and the safety in MRI-TRUS fusion image-guided prostate biopsy: multi-institutional study in Japan

Tokai University0 个研究点目标入组 400 人开始时间: 2020年11月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1. the patiens who have fatal disease 2. the patiens who are suspected as having progressive prostate cancer 3. the patiens who are suspected as having progressive prostate cancer with digital rectal examination 4. the patiens who are suspected as having progressive prostate cancer on MRI 5. the patiens who have abnormal blood coagulation 6. the patients who have the allergy for the anesthesia 7. the patients who were regarded as being inappropriate 8. the person with less than 20 years olds

研究者

相似试验